Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP5 | P45974 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 4/20 | 0.49 |
| ▸ | PPARA | Q07869 | 4/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | MPI | P34949 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28093688 | 0.98 | USP5 (0.61) | USP5SMN1; SMN2L3MBTL1MAPTPOLB | |
| Methane SCHEMBL28686261 | 0.98 | USP5 (0.61) | USP5SMN1; SMN2L3MBTL1MAPTPOLB | |
| Butane SCHEMBL10985150 | 0.96 | USP5 (0.59) | USP5SMN1; SMN2L3MBTL1MAPTPOLB | |
| SCHEMBL2627842 | 0.94 | L3MBTL1 (0.63) | USP5SMN1; SMN2L3MBTL1MAPTPOLB | |
| SCHEMBL269939 | 0.84 | USP5 (0.66) | USP5SMN1; SMN2L3MBTL1MAPTPOLB | |
| SCHEMBL30089581 | 0.84 | USP5 (0.85) | USP5SMN1; SMN2L3MBTL1POLBCYP2C9 | |
| SCHEMBL17577071 | 0.84 | USP5 (0.56) | USP5SMN1; SMN2L3MBTL1POLBCYP2C9 | |
| SCHEMBL2274688 | 0.83 | MAPT (0.50) | USP5SMN1; SMN2L3MBTL1MAPTPOLB | |
| SCHEMBL8051337 | 0.83 | SMN1; SMN2 (0.70) | SMN1; SMN2L3MBTL1MAPTHTTRAB9A | |
| SCHEMBL17049803 | 0.83 | SMN1; SMN2 (0.50) | USP5SMN1; SMN2L3MBTL1MAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-205838883-U | A kind of process units of cyclamen aldehyde precursor p-isopropyl β chlorine α methylbenzene acrylic aldehyde | 安徽华业香料股份有限公司 | 2016-12-28 | — | — | CN | claimed |
| CN-205838882-U | A kind of industrial installation of high-load cyclamen aldehyde | 安徽华业香料股份有限公司 | 2016-12-28 | — | — | CN | claimed |
| CN-106220486-A | A kind of synthetic method of high-load cyclamen aldehyde spice | 安徽华业香料股份有限公司 | 2016-12-14 | — | — | CN | claimed |
| CN-106187719-A | The synthetic method of cyclamen aldehyde precursor p-isopropyl β chlorine α methylbenzene acrylic aldehyde | 安徽华业香料股份有限公司 | 2016-12-07 | — | — | CN | claimed |
| CN-106187728-A | A kind of industrial process of high-load cyclamen aldehyde | 安徽华业香料股份有限公司 | 2016-12-07 | — | — | CN | claimed |
| CN-106187720-A | The industrial process of cyclamen aldehyde precursor p-isopropyl β chlorine α methylbenzene acrylic aldehyde | 安徽华业香料股份有限公司 | 2016-12-07 | — | — | CN | claimed |
| CN-104177298-A | 4, 4-disubstituted-4, 5-dihydro-1H-imidazole-5-one and derivatives thereof as well as synthesis method thereof | UNIV XIANGTAN | 2014-12-03 | — | — | CN | claimed |
| CN-114007660-B | Refreshing composition and method for atomizing refreshing composition by using heat-activated microfluidic cartridge | 宝洁公司 | 2024-07-05 | — | — | CN | disclosed |
| US-11998664-B2 | Ureteral stent and manufacture method therefor | JIANGSU BIOSURF BIOTECH CO., LTD (CN) | 2024-06-04 | — | — | US | disclosed |
| CN-114096283-B | Method of atomizing a fluid composition | 宝洁公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11938208-B2 | Antimicrobial mixture | SYMRISE AG (DE) | 2024-03-26 | — | — | US | disclosed |
| US-11873295-B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | PETRA PHARMA CORPORATION (US) | 2024-01-16 | — | — | US | disclosed |
| US-20230348369-A1 | NAMPT MODULATORS | CYTOKINETICS, INC. | 2023-11-02 | — | — | US | disclosed |
| EP-0052775-A2 | Process for the production of aldehydes and intermediate products | L. GIVAUDAN & CIE Société Anonyme (CH) | 1982-06-02 | — | — | EP | disclosed |
| US-4237306-A | ELECTROPHILIC REACTIONS WITH ALKYL ARYL KETONES TO PRODUCE METHYL ARYL ALKANOATES | EMERY INDUSTRIES, INC. (US) | 1980-12-02 | — | — | US | disclosed |
| US-4182730-A | Process for the preparation of substituted dihydrocinnamaldehydes via novel β-chlorocinnamaldehydes | GIVAUDAN CORPORATION (US) | 1980-01-08 | — | — | US | disclosed |
| US-4181803-A | 4'-SUBSTITUTED-2-METHYL-3-PIPERIDINO-PROPIOPHENONES; ANTISPASMODIC AGENTS, MUSCLE RELAXANTS | EISAI CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |
| US-4172955-A | REARRANGMENT OF A CINNAMALDEHYDE TO A PHENYLMALONDIALDEHYDE TETRAMETHYL DISACETAL | EMERY INDUSTRIES, INC. (US) | 1979-10-30 | — | — | US | disclosed |
| US-4067823-A | Thallium(III) reagents supported on montmorillonite clay minerals and oxythallation processes for utilizing same | EMERY INDUSTRIES, INC. (US) | 1978-01-10 | — | — | US | disclosed |
| US-3995047-A | Propiophenone derivatives in the treatment of pathological muscular conditions | EISAI CO., LTD. (JA) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11873295-B2 | Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of disease | PIK3CA, PIK3R4, PIK3R5 | USP5 4266/4885SMN1; SMN2 1813/4885L3MBTL1 3117/4885 |
| US-20230348369-A1 | NAMPT MODULATORS | NAMPT, NNT, NAPRT | USP5 4857/4885SMN1; SMN2 610/4885L3MBTL1 3643/4885 |
| US-11938208-B2 | Antimicrobial mixture | GNPAT, GMDS, DDOST | USP5 3068/4885SMN1; SMN2 4640/4885L3MBTL1 3747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.